ID   NLTP_HUMAN              Reviewed;         547 AA.
AC   P22307; A6NM69; B4DGJ9; B4DHP6; C9JC79; D3DQ37; E1B6W5; F2Z3J1;
AC   Q15432; Q16622; Q5VVZ1; Q6NXF4; Q99430;
DT   01-AUG-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   12-APR-2017, entry version 197.
DE   RecName: Full=Non-specific lipid-transfer protein;
DE            Short=NSL-TP;
DE            EC=2.3.1.176;
DE   AltName: Full=Propanoyl-CoA C-acyltransferase;
DE   AltName: Full=SCP-chi;
DE   AltName: Full=SCPX;
DE   AltName: Full=Sterol carrier protein 2;
DE            Short=SCP-2;
DE   AltName: Full=Sterol carrier protein X;
DE            Short=SCP-X;
GN   Name=SCP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM SCPX).
RC   TISSUE=Liver;
RX   PubMed=7698762; DOI=10.1006/geno.1994.1630;
RA   Ohba T., Rennert H., Pfeifer S.M., He Z., Yamamoto R., Holt J.A.,
RA   Billheimer J.T., Strauss J.F. III;
RT   "The structure of the human sterol carrier protein X/sterol carrier
RT   protein 2 gene (SCP2).";
RL   Genomics 24:370-374(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SCPX).
RC   TISSUE=Liver;
RX   PubMed=1718316; DOI=10.1089/dna.1991.10.559;
RA   He Z., Yamamoto R., Furth E.E., Schantz L.J., Naylor S.L., George H.,
RA   Billheimer J.T., Strauss J.F. III;
RT   "cDNAs encoding members of a family of proteins related to human
RT   sterol carrier protein 2 and assignment of the gene to human
RT   chromosome 1 p21-pter.";
RL   DNA Cell Biol. 10:559-569(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SCP2).
RC   TISSUE=Liver;
RX   PubMed=1703300; DOI=10.1073/pnas.88.2.463;
RA   Yamamoto R., Kallen C.B., Babalola G.O., Rennert H., Billheimer J.T.,
RA   Strauss J.F. III;
RT   "Cloning and expression of a cDNA encoding human sterol carrier
RT   protein 2.";
RL   Proc. Natl. Acad. Sci. U.S.A. 88:463-467(1991).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SCP2).
RC   TISSUE=Liver;
RX   PubMed=1483685;
RA   Yamamoto R.;
RT   "Localization of human sterol carrier protein 2 gene and cDNA
RT   expression in COS-7 cell.";
RL   Hokkaido Igaku Zasshi 67:839-848(1992).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 4 AND 8), AND
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-218 (ISOFORM 7).
RC   TISSUE=Brain, Caudate nucleus, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 6).
RA   Heil O., Ebert L., Hennig S., Henze S., Radelof U., Schneider D.,
RA   Korn B.;
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D.,
RA   Dunham A., Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A.,
RA   Jones M.C., Gillson C., Searle S., Zhou Y., Kokocinski F.,
RA   McDonald L., Evans R., Phillips K., Atkinson A., Cooper R., Jones C.,
RA   Hall R.E., Andrews T.D., Lloyd C., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Anderson F., Andrew R.W., Ashwell R.I.S., Aubin K.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Beasley H., Bethel G.,
RA   Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G.,
RA   Clee C., Cobley V., Collier R.E., Corby N., Coville G.J., Davies J.,
RA   Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R.,
RA   Hammond S., Harrison E.S.I., Hart E., Haugen E., Heath P.D.,
RA   Holmes S., Holt K., Howden P.J., Hunt A.R., Hunt S.E., Hunter G.,
RA   Isherwood J., James R., Johnson C., Johnson D., Joy A., Kay M.,
RA   Kershaw J.K., Kibukawa M., Kimberley A.M., King A., Knights A.J.,
RA   Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W., McLaren S.,
RA   Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C.,
RA   Subramanian S., Sycamore N., Tracey A., Tromans A., Van Helmond Z.,
RA   Wall M., Wallis J.M., White S., Whitehead S.L., Wilkinson J.E.,
RA   Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z., Coulson A.,
RA   Vaudin M., Sulston J.E., Durbin R.M., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND SCP2).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RG   The MGC Project Team;
RL   Submitted (MAR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 455-462; 512-522 AND 535-546, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAR-2005) to UniProtKB.
RN   [12]
RP   ALTERNATIVE PROMOTER USAGE, AND INDUCTION BY 4-HYDROXY-TAMOXIFEN.
RX   PubMed=14563822; DOI=10.1194/jlr.M300111-JLR200;
RA   Dansen T.B., Kops G.J., Denis S., Jelluma N., Wanders R.J., Bos J.L.,
RA   Burgering B.M., Wirtz K.W.;
RT   "Regulation of sterol carrier protein gene expression by the forkhead
RT   transcription factor FOXO3a.";
RL   J. Lipid Res. 45:81-88(2004).
RN   [13]
RP   INVOLVEMENT IN LDMN.
RX   PubMed=16685654; DOI=10.1086/503921;
RA   Ferdinandusse S., Kostopoulos P., Denis S., Rusch H., Overmars H.,
RA   Dillmann U., Reith W., Haas D., Wanders R.J., Duran M., Marziniak M.;
RT   "Mutations in the gene encoding peroxisomal sterol carrier protein X
RT   (SCPx) cause leukencephalopathy with dystonia and motor neuropathy.";
RL   Am. J. Hum. Genet. 78:1046-1052(2006).
RN   [14]
RP   MUTAGENESIS OF ASN-528 AND GLY-530, AND FUNCTION.
RX   PubMed=8300590;
RA   Seedorf U., Scheek S., Engel T., Steif C., Hinz H.-J., Assmann G.;
RT   "Structure-activity studies of human sterol carrier protein 2.";
RL   J. Biol. Chem. 269:2613-2618(1994).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-183; LYS-438 AND LYS-470,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [19]
RP   STRUCTURE BY NMR OF SCP2.
RX   PubMed=8243660; DOI=10.1016/0014-5793(93)80431-S;
RA   Szyperski T., Scheek S., Johansson J., Assmann G., Seedorf U.,
RA   Wuethrich K.;
RT   "NMR determination of the secondary structure and the three-
RT   dimensional polypeptide backbone fold of the human sterol carrier
RT   protein 2.";
RL   FEBS Lett. 335:18-26(1993).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 426-547 IN COMPLEX WITH PEX5,
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=17157249; DOI=10.1016/j.molcel.2006.10.024;
RA   Stanley W.A., Filipp F.V., Kursula P., Schueller N., Erdmann R.,
RA   Schliebs W., Sattler M., Wilmanns M.;
RT   "Recognition of a functional peroxisome type 1 target by the dynamic
RT   import receptor Pex5p.";
RL   Mol. Cell 24:653-663(2006).
RN   [21]
RP   VARIANT [LARGE SCALE ANALYSIS] ASP-155.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Mediates in vitro the transfer of all common
CC       phospholipids, cholesterol and gangliosides between membranes. May
CC       play a role in regulating steroidogenesis.
CC       {ECO:0000269|PubMed:17157249, ECO:0000269|PubMed:8300590}.
CC   -!- CATALYTIC ACTIVITY: 3-alpha,7-alpha,12-alpha-trihydroxy-5-beta-
CC       cholanoyl-CoA + propanoyl-CoA = CoA + 3-alpha,7-alpha,12-alpha-
CC       trihydroxy-24-oxo-5-beta-cholestanoyl-CoA.
CC   -!- SUBUNIT: Interacts with PEX5. {ECO:0000269|PubMed:17157249}.
CC   -!- INTERACTION:
CC       Q03135:CAV1; NbExp=3; IntAct=EBI-1050999, EBI-603614;
CC       P49817:Cav1 (xeno); NbExp=3; IntAct=EBI-1050999, EBI-1161338;
CC       Q15645:TRIP13; NbExp=4; IntAct=EBI-1050999, EBI-358993;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:17157249}.
CC       Mitochondrion {ECO:0000269|PubMed:17157249}. Note=Cytoplasmic in
CC       the liver and also associated with mitochondria especially in
CC       steroidogenic tissues.
CC   -!- SUBCELLULAR LOCATION: Isoform SCPx: Peroxisome. Note=Interaction
CC       with PEX5 is essential for peroxisomal import.
CC   -!- SUBCELLULAR LOCATION: Isoform SCP2: Mitochondrion {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative promoter usage, Alternative splicing; Named isoforms=8;
CC       Name=SCPx;
CC         IsoId=P22307-1; Sequence=Displayed;
CC       Name=SCP2;
CC         IsoId=P22307-2; Sequence=VSP_018977;
CC         Note=Contains a mitochondrial transit peptide at positions 1-20.
CC         {ECO:0000305};
CC       Name=3;
CC         IsoId=P22307-3; Sequence=VSP_042686, VSP_042687;
CC       Name=4;
CC         IsoId=P22307-4; Sequence=VSP_045187;
CC         Note=Produced by alternative splicing. No experimental
CC         confirmation available.;
CC       Name=5;
CC         IsoId=P22307-5; Sequence=VSP_018977, VSP_047269, VSP_047270;
CC       Name=6;
CC         IsoId=P22307-6; Sequence=VSP_018977, VSP_047268;
CC       Name=7;
CC         IsoId=P22307-7; Sequence=VSP_042686;
CC         Note=Produced by alternative splicing.;
CC       Name=8;
CC         IsoId=P22307-8; Sequence=VSP_047267;
CC         Note=Produced by alternative splicing.;
CC   -!- TISSUE SPECIFICITY: Liver, fibroblasts, and placenta.
CC   -!- INDUCTION: Up-regulated by 4-hydroxy-tamoxifen.
CC       {ECO:0000269|PubMed:14563822}.
CC   -!- DISEASE: Leukoencephalopathy, with dystonia and motor neuropathy
CC       (LDMN) [MIM:613724]: A syndrome characterized by
CC       leukoencephalopathy, dystonic head tremor, spasmodic torticollis
CC       and reduced tendon reflexes in lower extremities. Additional
CC       features include hyposmia, pathologic saccadic eye movements, a
CC       slight hypoacusis, accumulation of branched-chain pristanic acid
CC       in plasma, and the presence of abnormal bile alcohol glucuronides
CC       in urine. {ECO:0000269|PubMed:16685654}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: In the N-terminal section; belongs to the thiolase
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA03558.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U11313; AAB41286.1; -; Genomic_DNA.
DR   EMBL; U11297; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11299; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11300; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11301; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11302; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11303; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11304; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11305; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11306; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11307; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11308; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11309; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11310; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11311; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; U11312; AAB41286.1; JOINED; Genomic_DNA.
DR   EMBL; M75883; AAA03557.1; -; mRNA.
DR   EMBL; M75884; AAA03558.1; ALT_INIT; mRNA.
DR   EMBL; M55421; AAA03559.1; -; mRNA.
DR   EMBL; S52450; AAB24921.1; -; mRNA.
DR   EMBL; AK294631; BAG57810.1; -; mRNA.
DR   EMBL; AK295214; BAG58208.1; -; mRNA.
DR   EMBL; AK308105; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; CR995014; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL445183; CAH72590.1; -; Genomic_DNA.
DR   EMBL; AC099677; CAH72590.1; JOINED; Genomic_DNA.
DR   EMBL; CH471059; EAX06760.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX06761.1; -; Genomic_DNA.
DR   EMBL; BC005911; AAH05911.1; -; mRNA.
DR   EMBL; BC067108; AAH67108.1; -; mRNA.
DR   EMBL; CB997588; -; NOT_ANNOTATED_CDS; mRNA.
DR   CCDS; CCDS30719.1; -. [P22307-5]
DR   CCDS; CCDS41338.1; -. [P22307-3]
DR   CCDS; CCDS44149.1; -. [P22307-2]
DR   CCDS; CCDS44150.1; -. [P22307-6]
DR   CCDS; CCDS53317.1; -. [P22307-7]
DR   CCDS; CCDS53318.1; -. [P22307-8]
DR   CCDS; CCDS53319.1; -. [P22307-4]
DR   CCDS; CCDS572.1; -. [P22307-1]
DR   PIR; B40407; B40407.
DR   PIR; I38205; I38205.
DR   RefSeq; NP_001007099.1; NM_001007098.2. [P22307-3]
DR   RefSeq; NP_001007100.1; NM_001007099.2. [P22307-2]
DR   RefSeq; NP_001007101.1; NM_001007100.2. [P22307-6]
DR   RefSeq; NP_001007251.1; NM_001007250.2. [P22307-5]
DR   RefSeq; NP_001180528.1; NM_001193599.1. [P22307-8]
DR   RefSeq; NP_001180546.1; NM_001193617.1. [P22307-4]
DR   RefSeq; NP_002970.2; NM_002979.4. [P22307-1]
DR   RefSeq; XP_016857535.1; XM_017002046.1. [P22307-2]
DR   UniGene; Hs.476365; -.
DR   PDB; 1QND; NMR; -; A=425-547.
DR   PDB; 2C0L; X-ray; 2.30 A; B=426-547.
DR   PDBsum; 1QND; -.
DR   PDBsum; 2C0L; -.
DR   ProteinModelPortal; P22307; -.
DR   SMR; P22307; -.
DR   BioGrid; 112246; 38.
DR   IntAct; P22307; 11.
DR   MINT; MINT-3009685; -.
DR   STRING; 9606.ENSP00000360569; -.
DR   BindingDB; P22307; -.
DR   ChEMBL; CHEMBL5950; -.
DR   iPTMnet; P22307; -.
DR   PhosphoSitePlus; P22307; -.
DR   SwissPalm; P22307; -.
DR   BioMuta; SCP2; -.
DR   DMDM; 2507456; -.
DR   REPRODUCTION-2DPAGE; IPI00026105; -.
DR   EPD; P22307; -.
DR   MaxQB; P22307; -.
DR   PaxDb; P22307; -.
DR   PeptideAtlas; P22307; -.
DR   PRIDE; P22307; -.
DR   TopDownProteomics; P22307-1; -. [P22307-1]
DR   TopDownProteomics; P22307-2; -. [P22307-2]
DR   TopDownProteomics; P22307-4; -. [P22307-4]
DR   DNASU; 6342; -.
DR   Ensembl; ENST00000371509; ENSP00000360564; ENSG00000116171. [P22307-7]
DR   Ensembl; ENST00000371513; ENSP00000360568; ENSG00000116171. [P22307-3]
DR   Ensembl; ENST00000371514; ENSP00000360569; ENSG00000116171. [P22307-1]
DR   Ensembl; ENST00000407246; ENSP00000384569; ENSG00000116171. [P22307-8]
DR   Ensembl; ENST00000408941; ENSP00000386214; ENSG00000116171. [P22307-5]
DR   Ensembl; ENST00000430330; ENSP00000406636; ENSG00000116171. [P22307-6]
DR   Ensembl; ENST00000435345; ENSP00000396413; ENSG00000116171. [P22307-2]
DR   Ensembl; ENST00000488965; ENSP00000435783; ENSG00000116171. [P22307-5]
DR   Ensembl; ENST00000528311; ENSP00000434132; ENSG00000116171. [P22307-4]
DR   GeneID; 6342; -.
DR   KEGG; hsa:6342; -.
DR   UCSC; uc001cuq.3; human. [P22307-1]
DR   CTD; 6342; -.
DR   DisGeNET; 6342; -.
DR   GeneCards; SCP2; -.
DR   HGNC; HGNC:10606; SCP2.
DR   HPA; HPA027101; -.
DR   HPA; HPA027135; -.
DR   HPA; HPA027317; -.
DR   MalaCards; SCP2; -.
DR   MIM; 184755; gene.
DR   MIM; 613724; phenotype.
DR   neXtProt; NX_P22307; -.
DR   OpenTargets; ENSG00000116171; -.
DR   Orphanet; 163684; Leukoencephalopathy - dystonia - motor neuropathy.
DR   PharmGKB; PA35014; -.
DR   eggNOG; KOG1406; Eukaryota.
DR   eggNOG; KOG4170; Eukaryota.
DR   eggNOG; ENOG410XPRW; LUCA.
DR   GeneTree; ENSGT00530000062928; -.
DR   HOGENOM; HOG000221741; -.
DR   HOVERGEN; HBG006506; -.
DR   InParanoid; P22307; -.
DR   KO; K08764; -.
DR   OMA; HMEVMIN; -.
DR   OrthoDB; EOG091G026S; -.
DR   PhylomeDB; P22307; -.
DR   TreeFam; TF300574; -.
DR   BioCyc; MetaCyc:HS03991-MONOMER; -.
DR   BRENDA; 2.3.1.176; 2681.
DR   Reactome; R-HSA-193368; Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol.
DR   Reactome; R-HSA-2046106; alpha-linolenic acid (ALA) metabolism.
DR   Reactome; R-HSA-389887; Beta-oxidation of pristanoyl-CoA.
DR   ChiTaRS; SCP2; human.
DR   EvolutionaryTrace; P22307; -.
DR   GeneWiki; SCP2; -.
DR   GenomeRNAi; 6342; -.
DR   PRO; PR:P22307; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000116171; -.
DR   CleanEx; HS_SCP2; -.
DR   ExpressionAtlas; P22307; baseline and differential.
DR   Genevisible; P22307; HS.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005782; C:peroxisomal matrix; TAS:Reactome.
DR   GO; GO:0005777; C:peroxisome; IDA:UniProtKB.
DR   GO; GO:0043234; C:protein complex; IDA:UniProtKB.
DR   GO; GO:0015485; F:cholesterol binding; IDA:UniProtKB.
DR   GO; GO:0000062; F:fatty-acyl-CoA binding; IDA:UniProtKB.
DR   GO; GO:0036042; F:long-chain fatty acyl-CoA binding; IDA:UniProtKB.
DR   GO; GO:0070538; F:oleic acid binding; IDA:UniProtKB.
DR   GO; GO:0008526; F:phosphatidylinositol transporter activity; IDA:UniProtKB.
DR   GO; GO:0033814; F:propanoyl-CoA C-acyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0050632; F:propionyl-CoA C2-trimethyltridecanoyltransferase activity; EXP:Reactome.
DR   GO; GO:0005102; F:receptor binding; IPI:UniProtKB.
DR   GO; GO:0015248; F:sterol transporter activity; IBA:GO_Central.
DR   GO; GO:0036109; P:alpha-linolenic acid metabolic process; TAS:Reactome.
DR   GO; GO:0006699; P:bile acid biosynthetic process; TAS:Reactome.
DR   GO; GO:0033540; P:fatty acid beta-oxidation using acyl-CoA oxidase; TAS:Reactome.
DR   GO; GO:0032959; P:inositol trisphosphate biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1901373; P:lipid hydroperoxide transport; IDA:UniProtKB.
DR   GO; GO:0007031; P:peroxisome organization; IEA:Ensembl.
DR   GO; GO:0015914; P:phospholipid transport; IDA:UniProtKB.
DR   GO; GO:0032385; P:positive regulation of intracellular cholesterol transport; IDA:UniProtKB.
DR   GO; GO:0045940; P:positive regulation of steroid metabolic process; IDA:UniProtKB.
DR   GO; GO:0006701; P:progesterone biosynthetic process; IDA:UniProtKB.
DR   GO; GO:0072659; P:protein localization to plasma membrane; IDA:UniProtKB.
DR   GO; GO:0006694; P:steroid biosynthetic process; IDA:UniProtKB.
DR   Gene3D; 3.30.1050.10; -; 1.
DR   Gene3D; 3.40.47.10; -; 2.
DR   InterPro; IPR003033; SCP2_sterol-bd_dom.
DR   InterPro; IPR016039; Thiolase-like.
DR   InterPro; IPR020615; Thiolase_acyl_enz_int_AS.
DR   InterPro; IPR020617; Thiolase_C.
DR   InterPro; IPR020613; Thiolase_CS.
DR   InterPro; IPR020616; Thiolase_N.
DR   Pfam; PF02036; SCP2; 1.
DR   Pfam; PF02803; Thiolase_C; 1.
DR   Pfam; PF00108; Thiolase_N; 1.
DR   SUPFAM; SSF53901; SSF53901; 2.
DR   SUPFAM; SSF55718; SSF55718; 1.
DR   PROSITE; PS00098; THIOLASE_1; 1.
DR   PROSITE; PS00737; THIOLASE_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Alternative initiation;
KW   Alternative promoter usage; Alternative splicing; Complete proteome;
KW   Cytoplasm; Direct protein sequencing; Lipid transport; Lipid-binding;
KW   Mitochondrion; Peroxisome; Phosphoprotein; Polymorphism;
KW   Reference proteome; Transferase; Transport.
FT   CHAIN         1    547       Non-specific lipid-transfer protein.
FT                                /FTId=PRO_0000034091.
FT   DOMAIN      433    543       SCP2.
FT   MOTIF       545    547       Microbody targeting signal.
FT                                {ECO:0000255}.
FT   MOD_RES       3      3       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P11915}.
FT   MOD_RES     132    132       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     132    132       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     168    168       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     173    173       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     177    177       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     183    183       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     183    183       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     282    282       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     341    341       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     341    341       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     432    432       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     432    432       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     438    438       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     438    438       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     443    443       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     443    443       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     453    453       N6-acetyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     453    453       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     464    464       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     470    470       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     470    470       N6-succinyllysine; alternate.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     479    479       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     491    491       N6-acetyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     492    492       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     511    511       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     516    516       Phosphoserine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     522    522       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   MOD_RES     534    534       N6-succinyllysine.
FT                                {ECO:0000250|UniProtKB:P32020}.
FT   VAR_SEQ       1    404       Missing (in isoform SCP2, isoform 5 and
FT                                isoform 6). {ECO:0000303|PubMed:1483685,
FT                                ECO:0000303|PubMed:15489334,
FT                                ECO:0000303|PubMed:1703300,
FT                                ECO:0000303|Ref.10, ECO:0000303|Ref.6}.
FT                                /FTId=VSP_018977.
FT   VAR_SEQ       1     81       Missing (in isoform 4).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_045187.
FT   VAR_SEQ      43     66       Missing (in isoform 8).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_047267.
FT   VAR_SEQ      67    110       Missing (in isoform 3 and isoform 7).
FT                                {ECO:0000303|PubMed:14702039,
FT                                ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042686.
FT   VAR_SEQ     362    547       LAQCAELCWQLRGEAGKRQVPGAKVALQHNLGIGGAVVVTL
FT                                YKMGFPEAASSFRTHQIEAVPTSSASDGFKANLVFKEIEKK
FT                                LEEEGEQFVKKIGGIFAFKVKDGPGGKEATWVVDVKNGKGS
FT                                VLPNSDKKADCTITMADSDFLALMTGKMNPQSAFFQGKLKI
FT                                TGNMGLAMKLQNLQLQPGNAKL -> GHSCS (in
FT                                isoform 3).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_042687.
FT   VAR_SEQ     412    414       Missing (in isoform 6).
FT                                {ECO:0000303|Ref.6}.
FT                                /FTId=VSP_047268.
FT   VAR_SEQ     447    463       EGEQFVKKIGGIFAFKV -> IRRLTAQSQWLTQTSWL
FT                                (in isoform 5). {ECO:0000303|Ref.10}.
FT                                /FTId=VSP_047269.
FT   VAR_SEQ     464    547       Missing (in isoform 5).
FT                                {ECO:0000303|Ref.10}.
FT                                /FTId=VSP_047270.
FT   VARIANT     155    155       A -> D (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035706.
FT   MUTAGEN     528    528       N->D: Strongly reduces sterol carrier and
FT                                phosphatidylcholine transfer activity;
FT                                when associated with D-530.
FT                                {ECO:0000269|PubMed:8300590}.
FT   MUTAGEN     528    528       N->I: Strongly reduces sterol carrier and
FT                                phosphatidylcholine transfer activity.
FT                                {ECO:0000269|PubMed:8300590}.
FT   MUTAGEN     530    530       G->D: Strongly reduces sterol carrier and
FT                                phosphatidylcholine transfer activity;
FT                                when associated with D-528.
FT                                {ECO:0000269|PubMed:8300590}.
FT   CONFLICT     10     10       T -> A (in Ref. 1; AAB41286).
FT                                {ECO:0000305}.
FT   CONFLICT     56     56       A -> V (in Ref. 5; AK308105).
FT                                {ECO:0000305}.
FT   CONFLICT    116    116       V -> A (in Ref. 5; AK308105).
FT                                {ECO:0000305}.
FT   CONFLICT    341    341       K -> Q (in Ref. 5; BAG57810).
FT                                {ECO:0000305}.
FT   CONFLICT    393    393       G -> D (in Ref. 1; AAB41286).
FT                                {ECO:0000305}.
FT   CONFLICT    472    472       A -> D (in Ref. 4; AAB24921).
FT                                {ECO:0000305}.
FT   CONFLICT    482    482       K -> Q (in Ref. 4; AAB24921).
FT                                {ECO:0000305}.
FT   CONFLICT    501    501       D -> A (in Ref. 4; AAB24921).
FT                                {ECO:0000305}.
FT   CONFLICT    522    522       K -> P (in Ref. 4; AAB24921).
FT                                {ECO:0000305}.
FT   TURN        427    430       {ECO:0000244|PDB:2C0L}.
FT   HELIX       432    454       {ECO:0000244|PDB:2C0L}.
FT   STRAND      457    465       {ECO:0000244|PDB:2C0L}.
FT   HELIX       467    469       {ECO:0000244|PDB:2C0L}.
FT   STRAND      472    480       {ECO:0000244|PDB:2C0L}.
FT   STRAND      484    487       {ECO:0000244|PDB:1QND}.
FT   STRAND      494    500       {ECO:0000244|PDB:2C0L}.
FT   HELIX       501    508       {ECO:0000244|PDB:2C0L}.
FT   TURN        509    511       {ECO:0000244|PDB:2C0L}.
FT   HELIX       514    519       {ECO:0000244|PDB:2C0L}.
FT   STRAND      524    527       {ECO:0000244|PDB:2C0L}.
FT   HELIX       529    533       {ECO:0000244|PDB:2C0L}.
FT   HELIX       534    538       {ECO:0000244|PDB:2C0L}.
SQ   SEQUENCE   547 AA;  58994 MW;  29F7551465C7143A CRC64;
     MSSSPWEPAT LRRVFVVGVG MTKFVKPGAE NSRDYPDLAE EAGKKALADA QIPYSAVDQA
     CVGYVFGDST CGQRAIYHSL GMTGIPIINV NNNCATGSTA LFMARQLIQG GVAECVLALG
     FEKMSKGSLG IKFSDRTIPT DKHVDLLINK YGLSAHPVAP QMFGYAGKEH MEKYGTKIEH
     FAKIGWKNHK HSVNNPYSQF QDEYSLDEVM ASKEVFDFLT ILQCCPTSDG AAAAILASEA
     FVQKYGLQSK AVEILAQEMM TDLPSSFEEK SIIKMVGFDM SKEAARKCYE KSGLTPNDID
     VIELHDCFST NELLTYEALG LCPEGQGATL VDRGDNTYGG KWVINPSGGL ISKGHPLGAT
     GLAQCAELCW QLRGEAGKRQ VPGAKVALQH NLGIGGAVVV TLYKMGFPEA ASSFRTHQIE
     AVPTSSASDG FKANLVFKEI EKKLEEEGEQ FVKKIGGIFA FKVKDGPGGK EATWVVDVKN
     GKGSVLPNSD KKADCTITMA DSDFLALMTG KMNPQSAFFQ GKLKITGNMG LAMKLQNLQL
     QPGNAKL
//
